TSPAN18 inhibitors belong to a specific class of chemical compounds that have attracted attention in the realm of cell biology and membrane protein interactions. TSPAN18, also known as Tetraspanin-18, is a member of the tetraspanin family of proteins, which are known for their role in facilitating protein-protein interactions and organizing membrane microdomains, such as tetraspanin-enriched microdomains (TEMs) or tetraspanin webs. Tetraspanins like TSPAN18 are integral membrane proteins with four transmembrane domains and two extracellular loops, allowing them to interact with various partner proteins, including integrins, immunoglobulin superfamily members, and other tetraspanins. TSPAN18 is involved in regulating diverse cellular processes, including cell adhesion, migration, signaling, and immune responses. TSPAN18 inhibitors are chemical compounds designed to interact with TSPAN18, potentially influencing its role in mediating protein-protein interactions and organizing membrane microdomains.
The mechanism of action of TSPAN18 inhibitors typically involves their binding to TSPAN18, often at specific sites or domains within the protein structure. This interaction can lead to changes in the ability of TSPAN18 to interact with partner proteins and participate in the assembly of TEMs. Consequently, TSPAN18 inhibitors may affect a wide range of cellular processes, including the modulation of cell adhesion, signal transduction, and immune cell interactions. The study of TSPAN18 inhibitors is crucial in advancing our understanding of membrane microdomain organization and protein-protein interactions, offering insights into the molecular mechanisms that govern cell behavior and immune responses. Additionally, it contributes to the broader field of cell biology, providing valuable tools for investigating the roles of tetraspanins like TSPAN18 in various cellular contexts and their impact on membrane dynamics and cellular function.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Doxorubicin | 23214-92-8 | sc-280681 sc-280681A | 1 mg 5 mg | $176.00 $426.00 | 43 | |
Doxorubicin intercalates DNA, interfering with replication and transcription, which could lead to reduced expression of various genes, potentially including TSPAN18. | ||||||
Etoposide (VP-16) | 33419-42-0 | sc-3512B sc-3512 sc-3512A | 10 mg 100 mg 500 mg | $51.00 $231.00 $523.00 | 63 | |
Etoposide stabilizes the DNA-topoisomerase II complex, preventing re-ligation of DNA strands and potentially reducing transcription of genes like TSPAN18. | ||||||
Puromycin | 53-79-2 | sc-205821 sc-205821A | 10 mg 25 mg | $166.00 $322.00 | 436 | |
Puromycin causes premature chain termination during protein synthesis, potentially affecting overall protein expression, including TSPAN18. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Actinomycin binds to DNA at the transcription initiation complex, inhibiting elongation and potentially decreasing TSPAN18 mRNA synthesis. | ||||||
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $55.00 | 6 | |
Mithramycin binds to DNA and inhibits RNA polymerase, which could lead to reduced transcription of genes including TSPAN18. | ||||||
Chromomycin A3 | 7059-24-7 | sc-200907 | 10 mg | $260.00 | ||
Chromomycin A3 binds to GC-rich regions of DNA, inhibiting RNA synthesis, which may include the transcription of TSPAN18. | ||||||
Aphidicolin | 38966-21-1 | sc-201535 sc-201535A sc-201535B | 1 mg 5 mg 25 mg | $84.00 $306.00 $1104.00 | 30 | |
Aphidicolin selectively inhibits DNA polymerase, which can result in reduced mRNA transcription and potentially lower TSPAN18 levels. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A is an inhibitor of histone deacetylases, affecting chromatin structure and potentially gene expression, including TSPAN18. | ||||||
Fostriecin | 87860-39-7 | sc-202160 | 50 µg | $265.00 | 9 | |
Fostriecin inhibits topoisomerase II and phosphatases, which could result in altered gene expression patterns, potentially affecting TSPAN18. | ||||||
Ellipticine | 519-23-3 | sc-200878 sc-200878A | 10 mg 50 mg | $145.00 $569.00 | 4 | |
Ellipticine intercalates into DNA and can inhibit various DNA-processing enzymes, potentially leading to reduced TSPAN18 expression. | ||||||